TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

Phase III trials of COVID-19 vaccine start on Tuesday

  • Arya Dipa

    Bandung/Jakarta

Bandung/Jakarta   /   Mon, August 10 2020   /  01:00 am
In this picture taken on April 29, 2020, an engineer shows an experimental vaccine for the COVID-19 coronavirus that was tested at the Quality Control Laboratory at the Sinovac Biotech facilities in Beijing. - Sinovac Biotech, which is conducting one of the four clinical trials that have been authorised in China, has claimed great progress in its research and promising results among monkeys.(AFP/Nicolas Asfouri )

Indonesian scientists are set to start the phase III clinical trials of a potential COVID-19 vaccine developed by China-based biopharmaceutical company Sinovac Biotech on Tuesday in six different locations in the West Java provincial capital of Bandung. Padjadjaran University (Unpad) School of Medicine professor Kusnandi Rusmil, who is also the clinical trial research team leader, said the human trials would commence on Aug. 11 although the number of registered volunteers as of Thursday was still half the target. “So far, about 800 volunteers have registered [for the trials],” Kusnandi said on Thursday. The tester team was looking for a total of 1,620 volunteers, he said, and that volunteer registrations would be open until Aug. 31. The six locations chosen for the trials are the Unpad School of Medicine Education Hospital, an Unpad campus, as well as four communi...